Changes of subfoveal choroidal thickness after treated by Ranibizumab for choroidal neovascularization secondary to pathologic myopia

AIM:To observe the change of subfoveal choroidal thickness(SFCT)after intravitreal injections of anti-vascular endothelial growth factor monoclonal antibody Ranibizumab in patients with choroidal neovascularization(CNV)secondary to pathologic myopia(PM)and to research the relation between visual acu...

Full description

Bibliographic Details
Main Authors: Jian-Shu Yuan, Yue Wu, Yu-Wen Wang
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2016-05-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2016/5/201605028.pdf